M. S. Sabatine Et Al. , "Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease," NEW ENGLAND JOURNAL OF MEDICINE , vol.376, no.18, pp.1713-1722, 2017
Sabatine, M. S. Et Al. 2017. Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease. NEW ENGLAND JOURNAL OF MEDICINE , vol.376, no.18 , 1713-1722.
Sabatine, M. S., Giugliano, R. P., Keech, A. C., Honarpour, N., Wiviott, S. D., Murphy, S. A., ... Kuder, J. F.(2017). Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease. NEW ENGLAND JOURNAL OF MEDICINE , vol.376, no.18, 1713-1722.
Sabatine, Marc Et Al. "Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease," NEW ENGLAND JOURNAL OF MEDICINE , vol.376, no.18, 1713-1722, 2017
Sabatine, Marc S. Et Al. "Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease." NEW ENGLAND JOURNAL OF MEDICINE , vol.376, no.18, pp.1713-1722, 2017
Sabatine, M. S. Et Al. (2017) . "Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease." NEW ENGLAND JOURNAL OF MEDICINE , vol.376, no.18, pp.1713-1722.
@article{article, author={Marc S. Sabatine Et Al. }, title={Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease}, journal={NEW ENGLAND JOURNAL OF MEDICINE}, year=2017, pages={1713-1722} }